Cargando…

The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial

BACKGROUND: Vaccine hesitancy is one of the many factors impeding efforts to control the COVID-19 pandemic. Exacerbated by the COVID-19 infodemic, misinformation has undermined public trust in vaccination, led to greater polarization, and resulted in a high social cost where close social relationshi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkin, Javier A, McDowell, Michelle, Yau, Brian, Machiri, Sandra Varaidzo, Pal, Shanthi, Briand, Sylvie, Muneene, Derrick, Nguyen, Tim, Purnat, Tina D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997707/
https://www.ncbi.nlm.nih.gov/pubmed/36884269
http://dx.doi.org/10.2196/40753
_version_ 1784903311052242944
author Elkin, Javier A
McDowell, Michelle
Yau, Brian
Machiri, Sandra Varaidzo
Pal, Shanthi
Briand, Sylvie
Muneene, Derrick
Nguyen, Tim
Purnat, Tina D
author_facet Elkin, Javier A
McDowell, Michelle
Yau, Brian
Machiri, Sandra Varaidzo
Pal, Shanthi
Briand, Sylvie
Muneene, Derrick
Nguyen, Tim
Purnat, Tina D
author_sort Elkin, Javier A
collection PubMed
description BACKGROUND: Vaccine hesitancy is one of the many factors impeding efforts to control the COVID-19 pandemic. Exacerbated by the COVID-19 infodemic, misinformation has undermined public trust in vaccination, led to greater polarization, and resulted in a high social cost where close social relationships have experienced conflict or disagreements about the public health response. OBJECTIVE: The purpose of this paper is to describe the theory behind the development of a digital behavioral science intervention—The Good Talk!—designed to target vaccine-hesitant individuals through their close contacts (eg, family, friends, and colleagues) and to describe the methodology of a research study to evaluate its efficacy. METHODS: The Good Talk! uses an educational serious game approach to boost the skills and competences of vaccine advocates to have open conversations about COVID-19 with their close contacts who are vaccine hesitant. The game teaches vaccine advocates evidence-based open conversation skills to help them speak with individuals who have opposing points of view or who may ascribe to nonscientifically supported beliefs while retaining trust, identifying common ground, and fostering acceptance and respect of divergent views. The game is currently under development and will be available on the web, free to access for participants worldwide, and accompanied by a promotional campaign to recruit participants through social media channels. This protocol describes the methodology for a randomized controlled trial that will compare participants who play The Good Talk! game with a control group that plays the widely known noneducational game Tetris. The study will evaluate a participant’s open conversation skills, self-efficacy, and behavioral intentions to have an open conversation with a vaccine-hesitant individual both before and after game play. RESULTS: Recruitment will commence in early 2023 and will cease once 450 participants complete the study (225 per group). The primary outcome is improvement in open conversation skills. Secondary outcomes are self-efficacy and behavioral intentions to have an open conversation with a vaccine-hesitant individual. Exploratory analyses will examine the effect of the game on implementation intentions as well as potential covariates or subgroup differences based on sociodemographic information or previous experiences with COVID-19 vaccination conversations. CONCLUSIONS: The outcome of the project is to promote more open conversations regarding COVID-19 vaccination. We hope that our approach will encourage more governments and public health experts to engage in their mission to reach their citizens directly with digital health solutions and to consider such interventions as an important tool in infodemic management. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/40753
format Online
Article
Text
id pubmed-9997707
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-99977072023-03-10 The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial Elkin, Javier A McDowell, Michelle Yau, Brian Machiri, Sandra Varaidzo Pal, Shanthi Briand, Sylvie Muneene, Derrick Nguyen, Tim Purnat, Tina D JMIR Res Protoc Protocol BACKGROUND: Vaccine hesitancy is one of the many factors impeding efforts to control the COVID-19 pandemic. Exacerbated by the COVID-19 infodemic, misinformation has undermined public trust in vaccination, led to greater polarization, and resulted in a high social cost where close social relationships have experienced conflict or disagreements about the public health response. OBJECTIVE: The purpose of this paper is to describe the theory behind the development of a digital behavioral science intervention—The Good Talk!—designed to target vaccine-hesitant individuals through their close contacts (eg, family, friends, and colleagues) and to describe the methodology of a research study to evaluate its efficacy. METHODS: The Good Talk! uses an educational serious game approach to boost the skills and competences of vaccine advocates to have open conversations about COVID-19 with their close contacts who are vaccine hesitant. The game teaches vaccine advocates evidence-based open conversation skills to help them speak with individuals who have opposing points of view or who may ascribe to nonscientifically supported beliefs while retaining trust, identifying common ground, and fostering acceptance and respect of divergent views. The game is currently under development and will be available on the web, free to access for participants worldwide, and accompanied by a promotional campaign to recruit participants through social media channels. This protocol describes the methodology for a randomized controlled trial that will compare participants who play The Good Talk! game with a control group that plays the widely known noneducational game Tetris. The study will evaluate a participant’s open conversation skills, self-efficacy, and behavioral intentions to have an open conversation with a vaccine-hesitant individual both before and after game play. RESULTS: Recruitment will commence in early 2023 and will cease once 450 participants complete the study (225 per group). The primary outcome is improvement in open conversation skills. Secondary outcomes are self-efficacy and behavioral intentions to have an open conversation with a vaccine-hesitant individual. Exploratory analyses will examine the effect of the game on implementation intentions as well as potential covariates or subgroup differences based on sociodemographic information or previous experiences with COVID-19 vaccination conversations. CONCLUSIONS: The outcome of the project is to promote more open conversations regarding COVID-19 vaccination. We hope that our approach will encourage more governments and public health experts to engage in their mission to reach their citizens directly with digital health solutions and to consider such interventions as an important tool in infodemic management. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/40753 JMIR Publications 2023-03-08 /pmc/articles/PMC9997707/ /pubmed/36884269 http://dx.doi.org/10.2196/40753 Text en ©Javier A Elkin, Michelle McDowell, Brian Yau, Sandra Varaidzo Machiri, Shanthi Pal, Sylvie Briand, Derrick Muneene, Tim Nguyen, Tina D Purnat. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.03.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Elkin, Javier A
McDowell, Michelle
Yau, Brian
Machiri, Sandra Varaidzo
Pal, Shanthi
Briand, Sylvie
Muneene, Derrick
Nguyen, Tim
Purnat, Tina D
The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial
title The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial
title_full The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial
title_fullStr The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial
title_full_unstemmed The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial
title_short The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial
title_sort good talk! a serious game to boost people’s competence to have open conversations about covid-19: protocol for a randomized controlled trial
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997707/
https://www.ncbi.nlm.nih.gov/pubmed/36884269
http://dx.doi.org/10.2196/40753
work_keys_str_mv AT elkinjaviera thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT mcdowellmichelle thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT yaubrian thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT machirisandravaraidzo thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT palshanthi thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT briandsylvie thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT muneenederrick thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT nguyentim thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT purnattinad thegoodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT elkinjaviera goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT mcdowellmichelle goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT yaubrian goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT machirisandravaraidzo goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT palshanthi goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT briandsylvie goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT muneenederrick goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT nguyentim goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial
AT purnattinad goodtalkaseriousgametoboostpeoplescompetencetohaveopenconversationsaboutcovid19protocolforarandomizedcontrolledtrial